Zeyn, Yanira; Hausmann, Kristin; Halilovic, Melisa et al.
Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3LEUKEMIA. 2023
Fischer, Berenice; Kuebelbeck, Tanja; Kolb, Antonia et al.
IL-17A-driven psoriasis is critically dependent on IL-36 signalingFRONTIERS IN IMMUNOLOGY. Bd. 14. 2023
Leipe, Jan; Schmelz, Renate; Riemekasten, Gabriela et al.
Immune-mediated inflammatory diseases in Germany A cross-sectional analysis of comorbidities and pharmacotherapyZEITSCHRIFT FUR RHEUMATOLOGIE. 2023
Brans, R.; Bauer, A.; Becker, D. et al.
Impact of occupational contact allergy to 1,3-diphenylguanidine (1,3-DPG) in case of occupational skin diseaseDERMATOLOGIE IN BERUF UND UMWELT. Bd. 71. H. 2. 2023 S. 82-86
Monino-Romero, Sherezade; Kolkhir, Pavel; Szepfalusi, Zsolt et al.
In chronic spontaneous urticaria soluble FceRI is elevated and linked to atopy and chronic inducible urticariaCLINICAL AND TRANSLATIONAL ALLERGY. Bd. 13. H. 7. 2023
Schneider, Paul; Capeloa, Leon; Zhang, Heyang et al.
In vivo cancer-associated fibroblast specific gene silencing for anti-stromal therapy in primary liver cancer using novel siRNA loaded polypeptoide nanoparticlesJOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S28-S29
Bonnekoh, Hanna; Butze, Monique; Spittler, Sebastian et al.
Inhibition of interleukin-1 with rilonacept is not effective in cold urticaria-Results of a randomized, placebo-controlled studyCLINICAL AND TRANSLATIONAL ALLERGY. Bd. 13. H. 3. 2023
Weisshaar, Elke; Bentz, Philipp; Haufe, Eva et al.
Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermanyBRITISH JOURNAL OF DERMATOLOGY. Bd. 188. H. 3. 2023 S. 430-432
Weisshaar, Elke; Bentz, Philipp; Apfelbacher, Christian et al.
Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermanyACTA DERMATO-VENEREOLOGICA. Bd. 103. 2023
Gerdes, Sascha; Staubach, Petra; Dirschka, Thomas et al.
Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatmentBRITISH JOURNAL OF DERMATOLOGY. Bd. 189. H. 4. 2023 S. 381-391